Pediatric Infectious Diseases
Pfizer says COVID-19 Vaccine Safe, Effective for Adolescents in Trial
Pfizer and BioNTech’s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, the companies said
Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. Pediatric research, however, has led to dramatic changes in child health. Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. In 1975, a childhood diagnosis of acute lymphocytic leukemia (ALL) often meant certain death within five years, and […]
Pfizer and BioNTech’s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, the companies said
Copyright © 2025, A4M. All trademarks, registered or unregistered, are the property of their respective owners.